Converge Reports Fourth Quarter and Fiscal Year 2024 Results

In This Article:

TORONTO and GATINEAU, QC, March 5, 2025 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or the "Company") (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) is pleased to provide its financial results for the three months and fiscal year ended December 31, 2024. All figures are in Canadian dollars unless otherwise stated.

Converge Technology Solutions (CNW Group/Converge Technology Solutions Corp.)
Converge Technology Solutions (CNW Group/Converge Technology Solutions Corp.)

Fourth Quarter 2024 Highlights (year-over-year, unless otherwise noted):

  • Gross sales1 of $1.11 billion, an increase of $27.4 million or 2.5%;

  • Gross sales organic growth1 of 3.0% and gross profit organic growth1 of (0.0%);

  • Revenue of $680.8 million, an increase of $29.7 million or 4.6%;

  • Gross profit decreased 1.6% to $178.6 million, representing a gross margin of 26.7%;

  • Adjusted EBITDA1 increased by 3.0% to $47.9 million;

  • Cash from operating activities was $57.0 million, a decrease of $57.5 million, compared to $114.5 million for the comparative period in the prior year;

  • Returned $20.6 million of capital to shareholders1 as compared to $4.7 million return of capital to shareholders in Q4 FY23; and

  • Reduced net debt1 by $14.5 million from $127.9 million at Q3 2024; maintaining a leverage ratio1 below 0.7x.

Fiscal Year 2024 Highlights (year-over-year, unless otherwise noted):

  • Gross sales1 of $4.12 billion, an increase of $82.8 million or 2.1%;

  • Gross sales organic growth1 of 2.3% and gross profit organic growth1 of (0.7%);

  • Revenue of $2.59 billion, a decrease of $113.1 million or (4.2%);

  • Gross profit decreased 1.6% to $691.4 million, representing a gross margin of 26.7%;

  • Adjusted EBITDA1 decreased by 1.7% to $167.3 million;

  • Net loss of $181.0 million, an increase in loss of $174.6 million, driven by the non-cash impairment charge on the Germany segment of $176.1 million;

  • Returned $82.3 million of capital to shareholders1 as compared to $23.5 million return of capital to shareholders for the comparative period in prior year;

  • Cash from operating activities was $269.4 million, an increase of $39.9 million, compared to $229.5 million for the comparative period in the prior year; and

  • Reduced net debt1 by $96.4 million to $113.4 million, from $209.8 million at Q4 2023.

_________

1

This is a Non-IFRS measure (including non-IFRS ratio or supplementary financial measure) and not a recognized, defined or standardized measure under IFRS. See the "Non-IFRS Financial Measures" section of this press release for definitions, uses and a reconciliation of historical non-IFRS financial measures to the most directly comparable IFRS financial measures.

Financial Summary


Three months ended
December 31,


Fiscal year ended
December 31,

In $000s except per share amounts

2024

$

2023

$


2024

$

2023

$

Gross Sales1

1,106,055

1,078,663


4,120,717

4,037,921

Revenue

680,778

651,090


2,592,081

2,705,207

Gross profit (GP)

178,629

181,529


691,442

702,880

Gross profit (GP)%

26.2 %

27.9 %


26.7 %

26.0 %

Adjusted EBITDA1

47,885

46,505


167,315

170,294

Adjusted EBITDA as a % of GP1

26.8 %

25.6 %


24.2 %

24.2 %

Net loss

(9,174)

4,781


(180,986)

(6,393)

Adjusted net income1

45,586

38,214


130,289

108,399

Adjusted EPS1

0.23

0.19


0.66

0.53

Converge to be Acquired by H.I.G. Capital

On February 7, 2025, Converge announced that it had entered into an arrangement agreement (the "Arrangement Agreement") with an affiliate of H.I.G. Capital ("H.I.G."), whereby H.I.G will acquire all of the issued and outstanding common shares (the "Common Shares") of the Company (the "Transaction"). Under the terms of the Arrangement Agreement, shareholders will receive $5.50 per Common Share in cash, other than Common Shares held by certain shareholders who enter into rollover equity agreements, representing approximately 56% and 57% respective premiums to the closing price and 30-day volume weighted average price of the shares on the TSX on February 6, 2025, the last trading day prior to the date of the announcement of the Transaction. The purchase price of the Transaction values Converge at an enterprise value of approximately C$1.3 billion. Upon completion of the Transaction, the Company intends to apply to delist the Common Shares from all public markets and cease to be a reporting issuer under Canadian securities laws.